isomethyleugenol has been researched along with docetaxel anhydrous in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Gopisetty, G; Gordian, E; Hader, C; Navarro, L; Ramachandran, K; Reis, IM; Schulz, WA; Singal, R | 1 |
| Alley, WR; Goetz, JA; Hussein, A; Mann, BF; Matei, DE; Mechref, Y; Menning, N; Novotny, MV; Svoboda, M; Vasseur, JA | 1 |
| Chen, Y; Cui, X; Hu, H; Jiao, Y; Li, S; Lin, L; Lv, X; Song, E; Wang, M; Yao, H; Yu, F | 1 |
| Guo, B; Padi, SK; Tindall, DJ; Zhang, Q | 1 |
| Dong, Q; He, Y; Lei, M; Peng, Z; Yan, M; Zhang, X; Zhang, Z; Zhao, C | 1 |
| Arnold, RD; Cummings, BS; Glenn, TC; Kolli, RT; Moore, M; Scholpa, NE | 1 |
| Dong, BJ; Gao, WQ; Wang, F; Wang, N; Wang, Y; Zhu, Y | 1 |
7 other study(ies) available for isomethyleugenol and docetaxel anhydrous
| Article | Year |
|---|---|
Methylation-mediated repression of GADD45alpha in prostate cancer and its role as a potential therapeutic target.
Topics: Antineoplastic Agents; Azacitidine; Cell Cycle Proteins; Cell Line, Tumor; DNA Methylation; DNA Primers; DNA, Neoplasm; Docetaxel; Gene Expression Regulation, Neoplastic; Genome; Humans; Male; Methylation; Nuclear Proteins; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Taxoids; Up-Regulation | 2009 |
N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Tumor; Carbohydrate Sequence; Case-Control Studies; Docetaxel; Female; Fucose; Glycomics; Humans; Imatinib Mesylate; Immunoglobulin G; Methylation; Ovarian Neoplasms; Piperazines; Polysaccharides; Pyrimidines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Taxoids | 2012 |
The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2).
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Apoptosis; Azacitidine; Breast Neoplasms; Cell Line, Tumor; Cyclophosphamide; Decitabine; DNA Methylation; DNA, Neoplasm; Docetaxel; Down-Regulation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Heparan Sulfate Proteoglycans; Humans; Methylation; MicroRNAs; Neoplasm Proteins; RNA, Neoplasm; Taxoids | 2013 |
Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31.
Topics: Apoptosis; Cell Line, Tumor; Docetaxel; Down-Regulation; Drug Resistance, Neoplasm; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Silencing; Histones; Humans; Male; Methylation; MicroRNAs; Models, Biological; Polycomb Repressive Complex 2; Promoter Regions, Genetic; Prostatic Neoplasms; RNA, Small Interfering; Taxoids | 2014 |
A novel capsular tension ring as local sustained-release carrier for preventing posterior capsule opacification.
Topics: Animals; Antineoplastic Agents; Capsule Opacification; Cell Line; Delayed-Action Preparations; Docetaxel; Humans; Methacrylates; Methylation; Prostheses and Implants; Prosthesis Implantation; Rabbits; Taxoids; Tubulin Modulators | 2016 |
Nephrotoxicity of epigenetic inhibitors used for the treatment of cancer.
Topics: Acetylation; Animals; Antineoplastic Agents; Azacitidine; Cell Death; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Docetaxel; Epigenesis, Genetic; HEK293 Cells; Histones; Humans; Hydroxamic Acids; Kidney; Male; Methylation; Neoplasms; Oligopeptides; Prostatic Neoplasms; Rats; Taxoids | 2016 |
Wnt/β-catenin signaling contributes to prostate cancer heterogeneity through reciprocal suppression of H3K27 trimethylation.
Topics: Antineoplastic Agents; Apoptosis; Cell Line; Cell Proliferation; Docetaxel; Dose-Response Relationship, Drug; Humans; Male; Methylation; PC-3 Cells; Prostatic Neoplasms; Structure-Activity Relationship; Wnt Signaling Pathway | 2020 |